According to a story in the New York Times, Juul Labs is aggressively recruiting scientists to prove to the Food and Drug Administration, and to the public, that e-cigarettes offer more public health benefit than risk. If it fails to submit proper evidence by 2022, the agency could halt all sales.
An assistant professor of physiology at the University of Louisville medical school, was reportedly approached by a medical liaison for Juul who said collaborating with the company could be worth up to $200,000.
Juul recently launched a science website promoting its research grants. So far, Juul has reported funding studies only by the Centre for Substance Use Research, based in Scotland, and collaborating with a few independent labs. The Glasgow organization, which has done most of Juul’s outside research, is well known to tobacco control advocates, who have long criticized its studies for playing down the danger of youth addiction to e-cigarettes
